LEGN
$49.77
Legend Biotech Corp ADR
($1.74)
(3.38%)
LEGN
Earnings Whisper ®
N/A
3rd Quarter September 2022
Consensus:  ($0.68)
Revenue:  $45.54 Mil
Tuesday
Dec 13
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when LEGN reports earnings?
Beat
Meet
Miss

Where is LEGN's stock price going from here?
Up
Flat
Down
Stock chart of LEGN
Analysts
Summary of analysts' recommendations for LEGN
Score
Grade
Pivots
Resistance
$53.82
$52.88
$51.33

$50.39

Support
$48.84
$47.90
$46.35
Tweet
Growth
Description
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.